PCIF1-mediated m6Am RNA methylation modulates disease pathogenesis and progression

When the first nucleotide immediately downstream of the m 7 G cap at the 5′ end of eukaryotic mRNA is 2′-O-methyladenosine (Am), methylation at its N6 position can occur to form N6,2′-O-dimethyladenosine (m 6 Am). m 6 Am RNA modification is dynamically regulated by PCIF1 and FTO. In recent years, numerous studies have demonstrated that PCIF1-mediated m 6 Am modification participates in various biological processes, including the cell cycle, nutrient and energy metabolism, immune regulation and stress responses. Moreover, abnormal m 6 Am levels and dysregulated expression of related enzymes are widely involved in the tumorigenesis, progression and chemoresistance of tumors in the head and neck, digestive system, urinary system and nervous system, representing important factors affecting patient prognosis and treatment. Meanwhile, dysregulation of m 6 Am and its modifying enzymes also plays an important role in pain–anxiety comorbidity and periodontitis.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-13
DOI
https://doi.org/10.3389/fonc.2026.1966707
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

PCIF1-mediated m6Am RNA methylation modulates disease pathogenesis and progression

Tongbao Feng, Yingying Li, Ziteng Wang
2 links
Frontiers in Oncology
RNA modifications and cancer
article

PCIF1-mediated m6Am RNA methylation modulates disease pathogenesis and progression

Tongbao Feng, Yingying Li, Ziteng Wang
article en

Abstract

When the first nucleotide immediately downstream of the m 7 G cap at the 5′ end of eukaryotic mRNA is 2′-O-methyladenosine (Am), methylation at its N6 position can occur to form N6,2′-O-dimethyladenosine (m 6 Am). m 6 Am RNA modification is dynamically regulated by PCIF1 and FTO. In recent years, numerous studies have demonstrated that PCIF1-mediated m 6 Am modification participates in various biological processes, including the cell cycle, nutrient and energy metabolism, immune regulation and stress responses. Moreover, abnormal m 6 Am levels and dysregulated expression of related enzymes are widely involved in the tumorigenesis, progression and chemoresistance of tumors in the head and neck, digestive system, urinary system and nervous system, representing important factors affecting patient prognosis and treatment. Meanwhile, dysregulation of m 6 Am and its modifying enzymes also plays an important role in pain–anxiety comorbidity and periodontitis.

Frontiers in OncologyVol. 16
Nanjing Traditional Chinese Medicine Hospital (CN), Second Affiliated Hospital of Nanjing Medical University (CN), Changzhou No.2 People's Hospital (CN)
Jiangsu Commission of Health
Good health and well-being
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon